EN
HI
Summary
As of 29 Aug, 2026, Transgene Biotek stock price is ₹2.9. During the trading session, the stock has moved between an intraday low of ₹2.80 and an intraday high of ₹2.99. Over the last 52 weeks, Transgene Biotek has traded between ₹1.83 and ₹4.50.
The stock has recorded a trading volume of 19,842 shares, with a market capitalization of ₹75770000. Its Average Traded Price (ATP) is ₹2.86, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 365 @ ₹2.90.
Transgene Biotek has an upper circuit limit of ₹3.48 and a lower circuit limit of ₹2.32. The total value traded stands at ₹56748.12, and the delivery percentage for the day is 80.31%.
The stock is currently traded with a market lot size of 1. Transgene Biotek also offers a dividend yield of 0%.
Transgene Biotek share price chart
Transgene Biotek Share Key Metrics
Volume
19842.00
Market Cap
21.97 CR
LTQ@LTP
365@2.90
ATP
2.86
Var Margin
28.71 %
Circuit Range
2.32-3.48
Delivery %
80.31 %
Value
56748.12
ASM/GSM
No
Market Lot
1
Transgene Biotek Fundamentals
P/E Ratio
0
P/B Ratio
2.73
Div. Yield
0
Sector P/E
25.67
Sector P/B
2.74
Sec. Div. Yield
1.32
Transgene Biotek Resistance and Support
Pivot 2.93
Resistance
First Resistance
3.04
Second Resistance
3.21
Third Resistance
3.32
Support
First Support
2.76
Second Support
2.65
Third Support
2.48
Transgene Biotek Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 2.99 | 2.9 | 0.69% | 2.99 | 2.8 |
| Thu Aug 27 2026 | 2.88 | 2.88 | 2.49% | 3.09 | 2.81 |
| Wed Aug 26 2026 | 2.83 | 2.81 | -1.06% | 2.99 | 2.73 |
Transgene Biotek Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results & Others |
| 2026-05-29 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-07 | Audited Results |
| 2025-01-24 | Quarterly Results |
| 2024-11-12 | Quarterly Results & A.G.M. |
| 2024-08-10 | Quarterly Results |
Transgene Biotek News
Transgene Biotek Ltd - 526139 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.
Transgene Biotek reported Q1 FY27 revenue from operations of ₹6.00 lakhs, up from ₹4.95 lakhs YoY, and a net loss of ₹38.90 lakhs, narrowed from ₹43.37 lakhs YoY. The board also approved the appointment of Manisha Dubey & Associates as internal auditors for FY27 and extended the AGM date for FY26, pending RoC approval.
Aug 07 2026 11:42:58
Transgene Biotek Management
| Name | Position |
|---|---|
| K Koteswara Rao | Chairman & Managing Director |
| Sujana Kadiam | Non Executive Independent Director |
Transgene Biotek Similar Stocks
Rishabh Digha Steel & Allied Products Ltd.
37.49
-0.31 (0.82%)
Eforu Entertainment Ltd.
94.49
0.00 (0.00%)
Newtrac Foods & Beverages Ltd.
4.11
0.08 (1.99%)
Shree Karthik Papers Ltd.
7.35
0.06 (0.82%)
South Asian Enterprises Ltd.
0.00
0.00 (0.00%)
Veerkrupa Jewellers Ltd.
0.49
-0.01 (2.00%)
Hamps Bio Ltd.
24.49
0.00 (0.00%)
Ind-Agiv Commerce Ltd.
42.21
0.00 (0.00%)
Utique Enterprises Ltd.
3.93
0.08 (2.08%)
Transgene Biotek FAQs
The Buying Price of Transgene Biotek share is 2.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Transgene Biotek stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Transgene Biotek, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Transgene Biotek shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Transgene Biotek shares is 2.73. Useful to assess the stock's value relative to its book value.
To assess Transgene Biotek’s valuation compare Sector P/E, P/B which are 25.67 & 2.74 with sector averages, along with growth rates and financial metrics.
The Market Cap of Transgene Biotek is 21.97 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Transgene Biotek share price is 4.50 & 1.83. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Transgene Biotek belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
